Your browser doesn't support javascript.
Original Article Highlights From This Issue
The Journal of Allergy and Clinical Immunology: In Practice ; 10(6):A13-A16, 2022.
Article in English | ProQuest Central | ID: covidwho-1878433
ABSTRACT
Airway eosinophil rather than neutrophil count is the independent predictor of the longitudinal change in all lung function measures, even in patients who are being treated with inhaled or oral corticosteroids or antieosinophilic biologics. In future clinical trials that are investigating eosinophils targeting therapies, the addition of small airway function markers to the routinely used FEV1 might be more appropriate for the evaluation of lung function. The patients with IIA should be carefully monitored after the occupational asthma diagnosis, and the poor asthma outcomes highlight the need for preventive actions.As-Needed Use of Short-Acting β2-Agonists Alone Versus As-Needed Use of Short-Acting β2-Agonists Plus Inhaled Corticosteroids in Pediatric Patients with Mild Intermittent (Step 1) Asthma A Cost-Effectiveness Analysis Rodríguez-Martínez et al 1563 What is already known about this topic? What does this article add to our knowledge? A remote intervention can produce at least a 5% weight loss in a significant proportion of people with obesity and poorly controlled asthma, and this degree of weight loss is associated with improved asthma control.
Keywords

Full text: Available Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: The Journal of Allergy and Clinical Immunology: In Practice Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: The Journal of Allergy and Clinical Immunology: In Practice Year: 2022 Document Type: Article